First Sponsor (ADN) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
29 Oct, 2026Executive summary
PRC project presales and sales remained weak amid subdued sentiment; largely completed projects no longer pose material cashflow pressure, allowing a long-term sales approach.
Sydney House Residences launched presales in late September with satisfactory results; construction was 59% complete as at 21 October and remains on schedule for 3Q2027 completion.
European property operating income improved slightly in 3Q2025, while refurbishment disruption at Le Méridien Frankfurt weighed on hotel results.
Financial highlights
European portfolio operating income was €14.9m in 3Q2025, up 1.3% YoY; excluding Le Méridien Frankfurt, it rose 6.3% to €15.3m.
European hotel revenue was €33.91m in 3Q2025, down 3.5% YoY; EBITDA was €7.91m, down 2.0%. Excluding Le Méridien Frankfurt, EBITDA rose 7.3% to €8.23m.
Chengdu Wenjiang hotels recorded 3Q2025 revenue of RMB17.21m, down 13.0% YoY, and EBITDA of RMB2.29m, down 33.8%; 9M EBITDA was RMB10.07m, broadly stable YoY.
Outlook and guidance
Sydney House is expected to complete in 3Q2027; its hotel and retail components are 90.5%-owned, and 241 residences are 39.9%-owned.
Dreeftoren office completion is expected in 2Q2026 and residential completion in 4Q2026; the Puccini Hotel Milan is expected to open in late 2025 or early 2026.
Meerparc planning procedures are expected to start in 1H2026, with construction anticipated in 2H2027, subject to planning completion and building permit approval.
The Fenggang land tender is anticipated no earlier than 2H2026; rezoning at Time Zone is expected to complete in the later part of 4Q2025.
Latest events from First Sponsor
- European income grew as PRC presales stayed weak; NSI profit and S$244m rights proceeds bolstered 3Q.ADN
Q3 2024 TU - FY2023 profit fell 90.5% as European property income and equity proceeds supported resilience.ADN
H2 2023 - European income and hotel earnings improved as PRC property demand stayed weak.ADN
Q1 2024 TU - Revenue rose 27.2% and profit 12.4%, despite weak PRC pre-sales and higher financing costs.ADN
H1 2024 - NSI earnings lifted FY2024 profit despite PRC weakness and impairment charges.ADN
H2 2024 - Weak PRC presales contrast with stable European income and progress on loan recovery.ADN
Q1 2025 - Attributable profit rose 59.2% despite lower revenue and subdued PRC pre-sales.ADN
H1 2025 - Derivative losses drove FY2025 reported loss despite adjusted profit and stronger European hotels.ADN
H2 2025 - H1 attributable loss reached S$92.8m as derivatives and Humen impairment offset European NOI growth.ADN
H1 2026